| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $31.1M | -22.0% |
| SG&A Expense | $15.9M | +1.4% |
| Operating Income | -$61.1M | -2.4% |
| Interest Expense | $2.6M | — |
| Pre-tax Income | -$59.7M | -2.2% |
| Net Income | -$59.7M | -2.2% |
| EPS (Basic) | -$1.39 | -0.7% |
| EPS (Diluted) | -$1.39 | -0.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.8M | +80.2% |
| Short-term Investments | $52.2M | -8.3% |
| Current Assets | $73.0M | +1.7% |
| Total Assets | $75.2M | +1.0% |
| Current Liabilities | $7.2M | +17.7% |
| Long-term Debt | $49.8M | — |
| Total Liabilities | $58.5M | +618.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$46.4M | +11.5% |
| Capital Expenditures | $112K | -58.8% |
| Investing Cash Flow | $4.8M | +108.3% |
| Financing Cash Flow | $47.8M | +1447.7% |
| Free Cash Flow | -$46.5M | +11.8% |
| Stockholders' Equity |
| $16.8M |
| -74.7% |